Fatal Legionella longbeachae infection following heart transplantation

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 1, 1998, Pages 53-55

  Korman, T M ^a,b   Fuller, A ^a   Ibrahim, J ^a   Kaye, D ^a   Bergin, P ^a  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOPSY; BACTERIUM CULTURE; CASE REPORT; FATALITY; FEMALE; HEART TRANSPLANTATION; HUMAN; LEGIONNAIRE DISEASE; LUNG; PRIORITY JOURNAL;

CROSS INFECTION; FATAL OUTCOME; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HEART TRANSPLANTATION; HUMANS; LATEX FIXATION TESTS; LEGIONELLA; LEGIONELLOSIS; MIDDLE AGED; PNEUMONIA, BACTERIAL; POSTOPERATIVE COMPLICATIONS;

EID: 0031943059     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01584366     Document Type: Article

References (14)

1. Ampel NM, Wing EJ: Legionella infection in transplant patients. Seminars in Respiratory Infections 1990; 5: 30-37.
2. Patel R, Paya CV: Infections in solid-organ transplant recipients. Clinical Microbiology Reviews 1997, 10: 86-124.
3. Jernigan DB, Sanders LI, Waites KB, Brookings ES, Benson RF, Pappas PG: Pulmonary infection due to Legionella cincinnatiensis in renal transplant recipients: two cases and implications for laboratory diagnosis. Clinical Infectious Diseases 1994, 18: 385-389.
4. Rhomberg PR, Bale MJ, Jones RN: Application of the E test to antimicrobial susceptibility testing of Legionella spp. Diagnostic Microbiology and Infectious Disease 1994, 19: 175-178.
5. McKinney RM, Porschen RK, Edelstein PH, Bissett ML, Harris PP, Bondell SP, Steigerwalt AG, Weaver RE, Ein ME, Lindquist DS, Kops RS, Brenner DJ: Legionella longbeachae species nova, another etiological agent of human pneumonia. Annals of Internal Medicine 1981, 94: 739-743.
6. Communicable Diseases Surveillance: Legionellosis. Communicable Diseases Intelligence 1997, 21: 137.
7. Steele TW, Lanser J, Sangster N: Isolation of Legionella longbeachae serogroup 1 from potting mixes. Applied and Environmental Microbiology 1990, 56: 49-53.
8. Cameron S, Roder D, Walker C, Felheim J: Epidemiological characteristics of Legionella infection in South Australia: implications for disease control. Australia and New Zealand Journal of Medicine 1991, 21: 65-70.
9. Marrie TJ, Berzanson G, Haldane DJM, Burbridge S: Colonisation of the respiratory tract with Legionella pneumophila for 63 days before the onset of pneumonia. Journal of Infection 1992, 24: 81-86.
10. Bridge JA, Edelstein PH: Oropharyngeal colonization with Legionella pneumophila. Journal of Clinical Microbiology 1983, 18: 1108-1112.
11. Weeratna R, Marrie TJ, Logan SM, Hoskin D, Hoffman PS, Yates L, Burbridge S, Haldane D, Bezanson G: Legionnaires' disease in cardiac transplant patients: a cell-mediated response develops despite cyclosporine therapy. Journal of Infectious Diseases 1993, 168: 521-522.
12. Winslow WE, Steele TW: Indirect immunofluorescent antibody tests with Legionella longbeachae serogroup 1 antigen in confirmed infections. In: Barbaree JM, Breiman RF, Dufour AF (ed): Legionella. Current status and emerging perspectives. American Society for Microbiology, Washington DC, 1993, p. 17-19.
13. Nimmo G, Bull LZ: Comparative susceptibility of Legionella pneumophila and Legionella longbeachae to 12 antimicrobial agents. Journal of Antimicrobial Chemotherapy 1995, 36: 219-223.
14. Edelstein PH: Antimicrobial chemotherapy for Legionnaires' disease: a review. Clinical Infectious Diseases 1995, 21, Supplement 3: 265-276.